Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

226 to 250 of 322 results

AstraZeneca entices GSK R&D exec to head its Global Portfolio & Product Strategy

21-03-2013

Troubled Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced that Marc Dunoyer is to join the company…

AstraZenecaManagementPharmaceutical

Major overhaul of AstraZeneca R&D sites, and HQ move, will see 1,600 job cuts

19-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN), which is struggling with recent research disappointments…

AstraZenecaFinancialManagementPharmaceuticalResearch

European Patent Office maintains Pozen's PA/Vimovo patent

12-03-2013

US drug firm Pozen (Nasdaq: POZN) says that the Opposition Division of the European Patent Office has…

AstraZenecaEuropeInflammatory diseasesPatentsPharmaceuticalPozenVimovo

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Targacept regains rights to Alzheimer's drug candidate from AstraZeneca

06-03-2013

US biopharma drug developer Targacept (Nasdaq: TRGT) and Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AstraZenecaAZD1446LicensingNeurologicalPharmaceuticalResearchTargaceptTC-1734

AstraZeneca's Crestor patent rule invalid in Australia

05-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that the Federal Court of Australia…

Asia-PacificAstraZenecaCardio-vascularCrestorPatentsPharmaceutical

Encouraging results for AstraZeneca's naloxegol in OIC

26-02-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has announced high-level results from KODIAC-08, an open-label,…

AstraZenecaGastro-intestinalsnaloxegolNeurologicalPharmaceuticalResearch

US Court of Appeals confirms validity of AstraZeneca' Seroquel XR patent

15-02-2013

AstraZeneca announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit…

AstraZenecaGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Negative NICE guidance for Roche's Avastin and B-MS/AstraZeneca's Forxiga

01-02-2013

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has published draft…

AstraZenecaAvastinBristol-Myers SquibbDiabetesEuropeForxigaOncologyPharmaceuticalPricingRegulationRoche

AstraZeneca 2012 results continue to suffer from generic competition

31-01-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that, for full year 2012, revenues…

AstraZenecaFinancialPharmaceutical

Sweden's Orexo in respiratory research accord with AstraZeneca

28-01-2013

Swedish drug developer Orexo AB (STO: ORX) has entered into an agreement with Anglo-Swedish drug major…

AstraZenecaLicensingOrexo ABOX-CLIPharmaceuticalResearchRespiratory and Pulmonary

Positive outlook for Hutchison China MediTech, say analysts

21-01-2013

Analysts at Panmure Gordon & Co say they remain buyers of Hutchison China MediTech (LSE: HCM), which…

AstraZenecaFinancialHutchison MediTechLicensingPharmaceuticalvolitinib

AstraZeneca management shakeup sign of major restructuring leading to stock recovery, say analysts

17-01-2013

The management changes at Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this week do not…

AstraZenecaBrilintaBriliqueFinancialManagementMergers & AcquisitionsPharmaceuticalShire

Roche recruits US academic to spice up R&D; changes at AstraZeneca

16-01-2013

In a bid to invigorate its R&D productivity, Swiss drug major Roche (ROG: SIX) has appointed a well-known…

AstraZenecaManagementPharmaceuticalRoche

Scottish Medicines Consortium backs AstraZeneca/B-MS' Forxiga for type 2 diabetes

14-01-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and partner Bristol-Myers Squibb (NYSE: BMY) of the USA…

AstraZenecaBristol-Myers SquibbDiabetesEuropeForxigaPharmaceuticalPricingRegulation

Flu vaccine innovation needed to protect children, says GlobalData health care expert

13-01-2013

The last time the USA confronted a flu season this early, the virus claimed the lives of nearly 50,000…

Anti-viralsAstraZenecaFluarixFluMistGlaxoSmithKlinePharmaceuticalResearchVaccines

Evotec acquires Cell Culture Service GmbH; expands deal with AstraZeneca

07-01-2013

German biotech firm Evotec (EVT: TecDAX) has acquired all the shares in Cell Culture Service GmbH (CCS),…

AstraZenecaBiotechnologyCell Culture Service GmbHDiabetesEvotecLicensingMedImmuneMergers & AcquisitionsPharmaceutical

AstraZeneca to invest $1.2 billion in Russia by 2017; Pharmstandard deal with AVVA

28-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) plans to invest up to $1.2 billion in its development…

AstraZenecaAVVA PharmaceuticalsEuropeFinancialMarkets & MarketingPharmaceuticalPharmstandardProduction

AstraZeneca presents mixed data on fostamatinib in RA

13-12-2012

Shares of Anglo-Swedish drug major AstraZeneca (LSE: AZN) fell 2.1% to $47.88 in premarket US trading…

Anti-Arthritics/RheumaticsAstraZenecaBiotechnologyfostamatinibPharmaceuticalResearchRigel Pharmaceuticals

226 to 250 of 322 results

Back to top